New mRNA Cancer Vaccine Early Trial Sparks Hope in Oncology A new personalized mRNA cancer vaccine is making headlines after early Phase 1 data showed tumor reduction in 80% of patients. Promising, but larger trials will be key. #CancerResearch #mRNA #Immunotherapy /blog/mrna-cancer-vaccine-early-trial-response